BCAB vs IP · $5.9M cap vs P/E 43, $26.62B cap
Bioatla Inc (BCAB) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
IP does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the BCAB and IP stock pages for the full models.
Not investment advice.